RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants
Randomized Clinical Trial of High vs. Standard-Calorie Formula for Methadone-Exposed Infants
2 other identifiers
interventional
85
1 country
1
Brief Summary
Neonatal abstinence syndrome (NAS) symptoms contribute to poor infant weight gain. Early caloric enhancement for infants exposed to methadone is inexpensive, readily available, easy to implement and could improve early outcomes for these high-risk infants. We will conduct a preliminary randomized clinical trial of high-calorie vs. standard-calorie formula for methadone exposed infants to evaluate the adequacy of recruitment, protocol feasibility and estimates of whether high-calorie formula results in more normal patterns of weight loss and gain, less severe NAS symptoms and shorter hospital stays.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Apr 2010
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
June 26, 2014
CompletedFirst Posted
Study publicly available on registry
June 30, 2014
CompletedJune 30, 2014
June 1, 2014
3 years
June 26, 2014
June 26, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weight Patterns (gain and loss)
Weight loss and gain patterns will include days to return to birth weight, days to weight nadir (lowest point) and maximum percent weight loss.
Up to 3 weeks
Secondary Outcomes (1)
Neonatal abstinence syndrome (NAS) severity measures
Up to 3 weeks
Study Arms (2)
Standard-calorie infant formula
ACTIVE COMPARATORInfants assigned to this arm were fed standard-calorie infant formula (20 kcal/oz) from 72 hours of life until 21 days of age.
High-calorie infant formula
EXPERIMENTALInfants assigned to this arm were fed high-calorie infant formula (24 kcal/oz) from 72 hours of life until 21 days of age.
Interventions
Infants were randomized to be fed high calorie formula from 72 hours of life until age 21 days.
Infants were randomized to be fed standard calorie formula from 72 hours of life until age 21 days.
Eligibility Criteria
You may qualify if:
- Infants born to pregnant women, who are 18 to 45 years of age, participating in a licensed methadone maintenance treatment program
- planning to delivered at Magee if consented during pregnancy or delivered at Magee within the past 48 hours
You may not qualify if:
- Infants born weighing \<2200 grams or before 35 weeks
- Multiple gestation pregnancies (eg. twins)
- Infants with major congenital malformations that could interfere with feeding or weight gain, such as Downs syndrome, cleft lip or palate, congenital heart disease or cystic fibrosis will be excluded.
- Infants admitted to the NICU longer than 48 hours for a medical condition other than treatment of NAS
- Women who do not speak English will be excluded because study staff will not be able to communicate effectively.
- Women who intend to place their infant for adoption
- Women who plan on feeding their baby soy formula from birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Magee-Womens Hospital of UPMC
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Debra L Bogen, MD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Pediatrics
Study Record Dates
First Submitted
June 26, 2014
First Posted
June 30, 2014
Study Start
April 1, 2010
Primary Completion
April 1, 2013
Study Completion
December 1, 2013
Last Updated
June 30, 2014
Record last verified: 2014-06